Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.91
+0.13 (2.16%)
May 29, 2026, 12:27 PM EDT - Market open
Abeona Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Abeona Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $19.71. The average 1-year stock price forecast is 233.78% higher than the current stock price, while the lowest is $14 (+137.09%) and the highest is $28 (+374.17%).
Price Target: $19.71 (+233.78%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Abeona Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 → $20 | Buy | Reiterates | $15 → $20 | +238.70% | May 28, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $17 | Buy | Maintains | $17 | +187.89% | May 14, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +272.57% | May 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $20 | Buy | Reiterates | $20 | +238.70% | May 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $17 | Buy | Maintains | $17 | +187.89% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
65.19M
from 5.82M
Increased by 1,020.14%
Revenue Next Year
155.64M
from 65.19M
Increased by 138.74%
EPS This Year
-0.75
from 1.01
EPS Next Year
0.10
from -0.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 91.4M | 197.5M | ||||||
| Avg | 65.2M | 155.6M | ||||||
| Low | 41.5M | 122.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1,470.9% | 202.9% | ||||||
| Avg | 1,020.1% | 138.7% | ||||||
| Low | 612.7% | 88.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.44 | 0.66 | ||||||
| Avg | -0.75 | 0.10 | ||||||
| Low | -1.12 | -0.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.